STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2020

Compensation Related Costs [Abstract]

Stock option plan activity

	Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)
Balance at December 31, 2018		7,227,248		$	1.4		5.8
Granted		750,000		$	0.89		—
Expired/Cancelled		(421,242	)	$	1.52		—
Exercised		(351,334	)	$	0.47		—
Balance at December 31, 2019		7,204,672		$	1.32		5.3
Granted		2,450,000		$	0.14		—
Expired/Cancelled		(7,069,172	)	$	1.33		—
Exercised		—		$	—		—
Balance at December 31, 2020		2,585,500		$	0.19		9.2

RSUs activity

	RSU’s			Weighted-Average Issuance Price
Balance at December 31, 2019		—		$	—
Granted		3,857,416		$	0.15
Expired/Cancelled		(847,959	)	$	0.17
Vested		(2,164,341	)	$	0.14
Balance at December 31, 2020		845,106		$	0.14

Stock-based compensation related to equity options

	Year Ended December 31,
	2020		2019
Cost of revenue	$	15	$	13
General and administrative		550		347
Sales and marketing		163		148
Research and development		134		135
Total	$	862	$	643

Common stock reserved for future issuance

	Common Stock
Convertible preferred stock – Series A, Series A-1, Series B and Series D		540,677,052
Stock options outstanding		2,585,500
Restricted Stock Units		845,106
Warrants outstanding		753,775
Authorized for future grant under stock option plans		26,382,377